查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2030 年基因组学市场预测：按产品、服务、技术、应用、最终用户和地区进行的全球分析
市场调查报告书
商品编码
1383304

2030 年基因组学市场预测：按产品、服务、技术、应用、最终用户和地区进行的全球分析

Genomics Market Forecasts to 2030 - Global Analysis By Product (Consumables & Reagents, Instruments/Systems/Software and Other Products), Service, Study Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC预测，2023年全球基因组学市场规模将达到462亿美元，预计2030年将达到1,184亿美元，预测期内年复合成长率为14.4%。

生物体整个基因组或基因集合的研究是基因体学科学领域的核心。生物体中的所有基因、它们的作用、相互作用以及 DNA 的结构和排列都得到了分析和表征。它在许多领域也有应用，包括医学、农业和演化生物学。在基因组研究中，DNA序列测定和生物资讯学等技术经常用于收集和解释遗传资料。

据美国癌症研究所称，到 2040 年，将有 2,950 万新发癌症病例，并有 1,640 万癌症相关死亡病例。

专业医学中的基因组学

许多製药公司正在增加对个人化医疗研究的投资。个人化医疗使医生能够确定患者的确切需求并相应地开出药物和治疗方法。此策略可确保更好的医疗保健结果。个人化医疗业务的成长将为参与企业创造许多机会。

处理精密设备

基因编辑、扩增、定序和多重分析只是基因组研究中使用的一些复杂而精细的技术。这些技术包括使用先进的工具，如定序仪、离心机、分析仪、液体处理设备、PCR 设备和微阵列设备。因此，使用所有设备时必须格外小心。处理如此精密的设备是市场成长的主要障碍。

癌症发生率增加

癌症的流行和次世代定序仪在癌症研究中的日益广泛使用是市场扩张的关键因素。基因组学正在改变癌症的识别和治疗方式。由于基因组研究，检测血液样本中癌症的方法正在不断改进。基因组研究导致遗传性癌症筛检测试的增加。因此，由于癌症盛行率的上升以及基因组学在癌症诊断和治疗中的有效应用，市场正在扩大。

成本和承受能力

儘管核酸定序技术取得了进步，但全基因组序列测定和全面的基因组分析仍然是最昂贵的基因组测试和分析之一。基因组学在临床实践中的广泛使用受到基因检测及其解释相关的高成本的限制，特别是在资源有限的地区和经济弱势群体中。基因组产品和服务的可得性和可近性也受到财务因素的影响，限制了产业的扩张。

COVID-19 的影响：

在大流行的早期阶段，COVID-19 的影响略有上升。这是由于个人化医疗、癌症研究和其他研究的配合措施减少。疫情也扰乱了整个市场，导致售后服务难以提供，一些学术机构暂时关闭。为了检查病毒的遗传物质，该研究所采用了聚合酶炼式反应（PCR）和次世代定序仪（NGS）。

预计途径分析部分在预测期内将是最大的

路径分析部分预计将在预测期内成为最大的部分。途径分析最迅速扩展的应用是下一代治疗方法的创建。自从临床基因组学和客製化治疗出现以来，基于途径的分析引起了人们的兴趣。这主要归功于遗传学和个体化疗法提供的帮助，以详细研究导航疾病网络和信号途径的能力。

研究机构部门预计在预测期内年复合成长率最高

研究机构领域预计在预测期内年复合成长率最高。以基因组学为重点的研究、公共和私人基金会的资金筹措、商业合作伙伴关係等是该细分市场主导基因组学服务市场的部分原因。此外，由于与其他学术机构、医院和生物技术公司的合作研究，研究机构类别预计将在预测期内快速成长。

比最大的地区

在研究机构和製药巨头的支持下，预计北美在预测期内将占据最大的市场占有率。由于基因表现对人类健康的影响，基因组学现已成为所有疾病研究和治疗开发的关键组成部分。此外，支持该行业不断扩大技术进步的最先进的医疗保健基础设施的存在以及该地区对生物技术服务不断增长的需求预计将支持该地区的成长。

复合年复合成长率最高的地区：

由于诊断和新疗法中基因组学应用的需求不断增加，以应对不断增加的疾病发生率，预计亚太地区在预测期内将保持最高的年复合成长率。此外，癌症等慢性病盛行率的上升、政府研究经费的增加以及消费者意识的提高，都有助于该区域市场的扩张。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球基因组市场：副产品

  • 消耗品和试剂
  • 设备/系统/软体
  • 其他产品

第6章全球基因组市场：依服务分类

  • 核心基因组学服务
  • 计算服务
  • 基于NGS的服务
  • 生物标誌物翻译服务
  • 其他服务

第7章全球基因组市场：依技术分类

  • 表观基因
    • 染色质免疫沉淀（ChIP 和 ChIP-Seq）
    • 染色质可及性测定
    • 高解析度熔体 (HRM)
    • 亚硫酸氢盐序列
    • 甲基化 DNA 免疫沉淀 (MeDIP)
    • 微阵列分析
  • 生物标记发现
    • 实时萤光定量PCR
    • 质谱
    • 微阵列分析
    • 统计分析
    • DNA序列测定
    • 生物资讯学
  • 途径分析
    • 微阵列分析
    • 蛋白质体学工具
    • 实时萤光定量PCR
    • 基于微珠的分析
  • 功能基因体学
    • 实时萤光定量PCR
    • 突变分析
    • RNA干扰
    • 单核苷酸多态性分析
    • 转染
    • 微阵列分析
  • 其他技术

第8章全球基因体学市场：依应用分类

  • 农业和动物研究
  • 药物研发发现与开发
  • 其他用途
    • 生物燃料研究
    • 海洋研究
    • 食品工业
    • 法医学

第9章全球基因组市场：依最终用户分类

  • 製药和生物技术公司
  • 医院
  • 诊断中心
  • 学术机构
  • 临床研究
  • 医疗机构
  • 其他最终用户

第10章全球基因组市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第11章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第12章公司简介

  • BGI Genomics
  • Myriad Genetics, Inc.
  • Agilent Technologies
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific, Inc.
  • Eurofins Scientific
  • Danaher Corporation
  • Eppendorf AG
  • Bio-Rad Laboratories, Inc.
  • Color Genomics, Inc.
  • Agilent Technologies
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Illumina, Inc.
  • Oxford Nanopore Technologies
  • Quest Diagnostics Incorporated
  • Pacific Biosciences of California, Inc.
  • Color Health, Inc.
Product Code: SMRC24154

According to Stratistics MRC, the Global Genomics Market is accounted for $46.2 billion in 2023 and is expected to reach $118.4 billion by 2030 growing at a CAGR of 14.4% during the forecast period. The study of an organism's whole genome, or collection of genes, is at the center of the scientific discipline known as genomics. All genes, their roles, interactions, and the structure and arrangement of the DNA within an organism are analyzed and characterized. It also has many applications in fields including medicine, agriculture, evolutionary biology, and more. Techniques like DNA sequencing and bioinformatics are frequently used in genomic research to collect and interpret genetic data.

According to the National Cancer Institute, by 2040, the number of new cancer cases is expected to rise by 29.5 million, while cancer-related fatalities will rise by 16.4 million.

Market Dynamics:

Driver:

Genomics in specialty medicine

Numerous pharmaceutical firms are making growing investments in the study of tailored medicine. With the use of personalized medicine, doctors can pinpoint a patient's precise needs and then prescribe medications and therapies in response. Better healthcare results are ensured by this strategy. Numerous possibilities for market participants will arise as a result of the growth of the customized medicine business.

Restraint:

Delicate instrument handling

Gene editing, amplification, sequencing, and multiplexing are just a few of the complicated and delicate techniques used in genomic investigations. These techniques include the use of sophisticated tools, including sequencers, centrifuges, analyzers, liquid handling equipment, and PCR and microarray equipment. Therefore, extreme caution must be used when using all of the devices. Handling such delicate devices is a significant market growth inhibitor.

Opportunity:

Increasing cancer rates

The prevalence of cancer and the growing use of next-generation sequencing in cancer research are important drivers of the market's expansion. The way cancer is identified and treated is changing as a result of genomics. The methods for detecting cancer from a blood sample are getting better because to genome research. Genomic research has led to a rise in hereditary cancer screening tests. As a result, the market is expanding due to the rising incidence of cancer and the effective use of genomics in cancer diagnosis and treatment.

Threat:

Cost and affordability

Despite improvements in DNA sequencing technology, whole genome sequencing and comprehensive genomic profiling are among the most costly genomic tests and analyses. The broad use of genomics in clinical practice is constrained by the high costs involved with genetic testing and interpretation, particularly in locations with limited resources or for people with poor financial means. The availability and accessibility of genomic goods and services are also impacted by financial a factor, which restrains the expansion of the industry.

COVID-19 Impact:

The early stage of the pandemic saw a little negative rise in the COVID-19 effect. This was caused by a decline in personalized medicine, cancer research, and other research efforts. The epidemic also caused difficulties in delivering post-sales services and the temporary closure of some academic institutions, which disrupted the market as a whole. To examine viral genetic material, laboratories employed the polymerase chain reaction (PCR) and next-generation sequencing (NGS).

The pathway analysis segment is expected to be the largest during the forecast period

The pathway analysis segment is expected to be the largest during the forecast period. One of the most rapidly expanding uses of route analysis is the creation of next-generation therapies. Since the advent of clinical genomics and tailored treatments, pathway-based analysis has drawn increased interest. This is mostly due to the assistance provided by genetics and individualized medicines for the in-depth investigation of the capacity to navigate illness networks and signaling pathways.

The research institutes segment is expected to have the highest CAGR during the forecast period

The research institutes segment is expected to have the highest CAGR during the forecast period. Researchers with a focus on genomics, financing from public and private foundations, and business partnerships are some of the reasons that contribute to the segment's dominance in the market for genomics services. Additionally, the research institutes category is anticipated to grow faster throughout the projection period due to collaborations with other academic institutions, hospitals, and biotechnology firms.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to the support of research institutes and pharmaceutical giants. Due to the effects of genetic expression on human health, genomics is now a crucial component of all illness research and therapeutic development. Additionally, the presence of cutting-edge healthcare infrastructure, which supports the expansion of technical advancements in this industry, and rising demand for biotechnology services in the area are anticipated to support regional growth.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period due to increased demand for genomics applications in diagnostics and the growing demand for novel therapeutic drugs to fight the increased incidence of diseases. Additionally, the rising incidence of chronic illnesses like cancer, greater government funding for research, and growing consumer awareness all contribute to the expansion of regional markets.

Key players in the market

Some of the key players in Genomics market include: BGI Genomics, Myriad Genetics, Inc., Agilent Technologies, Quest Diagnostics Incorporated, Thermo Fisher Scientific, Inc., Eurofins Scientific, Danaher Corporation, Eppendorf AG, Bio-Rad Laboratories, Inc., Color Genomics, Inc., Agilent Technologies, F. Hoffmann-La Roche Ltd., GE Healthcare, Illumina, Inc., Oxford Nanopore Technologies, Quest Diagnostics Incorporated, Pacific Biosciences of California, Inc. and Color Health, Inc.

Key Developments:

In June 2023, BGI Genomics was recognized as the GB/T 35770-2022/ISO 37301 Compliance Management System accreditation-approved company, after the extensive evaluation of BSI, a global testing, standardization, and certification authority.

In June 2023, Myriad Genetics and The University of Texas MD Anderson Cancer Center announced their collaboration aimed at metastatic renal cell carcinoma treatment selection and response research and incorporating Myriad's minimal residual disease testing platform based on whole genome sequencing.

In April 2023, Bio-Rad Laboratories, Inc. pivoted their measurable residual disease (MRD) genomics research via a half dozen collaborations with companies and institutions to launch their new QX600™ Droplet Digital™ PCR System.

Products Covered:

  • Consumables & Reagents
  • Instruments/Systems/Software
  • Other Products

Services Covered:

  • Core Genomics Services
  • Computational Services
  • NGS-based Services
  • Biomarker Translation Services
  • Other Services

Technologies Covered:

  • Epigenomics
  • Biomarker Discovery
  • Pathway Analysis
  • Functional Genomics
  • Other Technologies

Applications Covered:

  • Agriculture and Animal research
  • Drug Discovery and Development
  • Other Applications

End Users Covered:

  • Pharmaceutical & Biotechnology Companies
  • Hospitals
  • Diagnostics Centers
  • Academic Institutes
  • Clinical Research
  • Healthcare Facilities
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.7 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Genomics Market, By Product

  • 5.1 Introduction
  • 5.2 Consumables & Reagents
  • 5.3 Instruments/Systems/Software
  • 5.4 Other Products

6 Global Genomics Market, By Service

  • 6.1 Introduction
  • 6.2 Core Genomics Services
  • 6.3 Computational Services
  • 6.4 NGS-based Services
  • 6.5 Biomarker Translation Services
  • 6.6 Other Services

7 Global Genomics Market, By Technology

  • 7.1 Introduction
  • 7.2 Epigenomics
    • 7.2.1 Chromatin Immunoprecipitation (ChIP & ChIP-Seq)
    • 7.2.2 Chromatin Accessibility Assays
    • 7.2.3 High-Resolution Melt (HRM)
    • 7.2.4 Bisulfite Sequencing
    • 7.2.5 Methylated DNA Immunoprecipitation (MeDIP)
    • 7.2.6 Microarray Analysis
  • 7.3 Biomarker Discovery
    • 7.3.1 Real-time PCR
    • 7.3.2 Mass Spectrometry
    • 7.3.3 Microarray Analysis
    • 7.3.4 Statistical Analysis
    • 7.3.5 DNA Sequencing
    • 7.3.6 Bioinformatics
  • 7.4 Pathway Analysis
    • 7.4.1 Microarray Analysis
    • 7.4.2 Proteomics Tools
    • 7.4.3 Real-time PCR
    • 7.4.4 Bead-Based Analysis
  • 7.5 Functional Genomics
    • 7.5.1 Real-Time PCR
    • 7.5.2 Mutational Analysis
    • 7.5.3 RNA Interference
    • 7.5.4 SNP Analysis
    • 7.5.5 Transfection
    • 7.5.6 Microarray Analysis
  • 7.6 Other Technologies

8 Global Genomics Market, By Application

  • 8.1 Introduction
  • 8.2 Agriculture and Animal research
  • 8.3 Drug Discovery and Development
  • 8.4 Other Applications
    • 8.4.1 Biofuel Research
    • 8.4.2 Marine Research
    • 8.4.3 Food Industry
    • 8.4.4 Forensics

9 Global Genomics Market, By End User

  • 9.1 Introduction
  • 9.2 Pharmaceutical & Biotechnology companies
  • 9.4 Hospitals
  • 9.5 Diagnostics Centers
  • 9.6 Academic Institutes
  • 9.8 Clinical Research
  • 9.9 Healthcare Facilities
  • 9.9 Other End Users

10 Global Genomics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 BGI Genomics
  • 12.2 Myriad Genetics, Inc.
  • 12.3 Agilent Technologies
  • 12.4 Quest Diagnostics Incorporated
  • 12.5 Thermo Fisher Scientific, Inc.
  • 12.6 Eurofins Scientific
  • 12.7 Danaher Corporation
  • 12.7 Eppendorf AG
  • 12.9 Bio-Rad Laboratories, Inc.
  • 12.10 Color Genomics, Inc.
  • 12.11 Agilent Technologies
  • 12.12 F. Hoffmann-La Roche Ltd.
  • 12.12 GE Healthcare
  • 12.14 Illumina, Inc.
  • 12.15 Oxford Nanopore Technologies
  • 12.16 Quest Diagnostics Incorporated
  • 12.17 Pacific Biosciences of California, Inc.
  • 12.17 Color Health, Inc.

List of Tables

  • Table 1 Global Genomics Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Genomics Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Genomics Market Outlook, By Consumables & Reagents (2021-2030) ($MN)
  • Table 4 Global Genomics Market Outlook, By Instruments/Systems/Software (2021-2030) ($MN)
  • Table 5 Global Genomics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 6 Global Genomics Market Outlook, By Service (2021-2030) ($MN)
  • Table 7 Global Genomics Market Outlook, By Core Genomics Services (2021-2030) ($MN)
  • Table 8 Global Genomics Market Outlook, By Computational Services (2021-2030) ($MN)
  • Table 9 Global Genomics Market Outlook, By NGS-based Services (2021-2030) ($MN)
  • Table 10 Global Genomics Market Outlook, By Biomarker Translation Services (2021-2030) ($MN)
  • Table 11 Global Genomics Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 12 Global Genomics Market Outlook, By Technology (2021-2030) ($MN)
  • Table 13 Global Genomics Market Outlook, By Epigenomics (2021-2030) ($MN)
  • Table 14 Global Genomics Market Outlook, By Chromatin Immunoprecipitation (ChIP & ChIP-Seq) (2021-2030) ($MN)
  • Table 15 Global Genomics Market Outlook, By Chromatin Accessibility Assays (2021-2030) ($MN)
  • Table 16 Global Genomics Market Outlook, By High-Resolution Melt (HRM) (2021-2030) ($MN)
  • Table 17 Global Genomics Market Outlook, By Bisulfite Sequencing (2021-2030) ($MN)
  • Table 18 Global Genomics Market Outlook, By Methylated DNA Immunoprecipitation (MeDIP) (2021-2030) ($MN)
  • Table 19 Global Genomics Market Outlook, By Microarray Analysis (2021-2030) ($MN)
  • Table 20 Global Genomics Market Outlook, By Biomarker Discovery (2021-2030) ($MN)
  • Table 21 Global Genomics Market Outlook, By Real-time PCR (2021-2030) ($MN)
  • Table 22 Global Genomics Market Outlook, By Mass Spectrometry (2021-2030) ($MN)
  • Table 23 Global Genomics Market Outlook, By Microarray Analysis (2021-2030) ($MN)
  • Table 24 Global Genomics Market Outlook, By Statistical Analysis (2021-2030) ($MN)
  • Table 25 Global Genomics Market Outlook, By DNA Sequencing (2021-2030) ($MN)
  • Table 26 Global Genomics Market Outlook, By Bioinformatics (2021-2030) ($MN)
  • Table 27 Global Genomics Market Outlook, By Pathway Analysis (2021-2030) ($MN)
  • Table 28 Global Genomics Market Outlook, By Microarray Analysis (2021-2030) ($MN)
  • Table 29 Global Genomics Market Outlook, By Proteomics Tools (2021-2030) ($MN)
  • Table 30 Global Genomics Market Outlook, By Real-time PCR (2021-2030) ($MN)
  • Table 31 Global Genomics Market Outlook, By Bead-Based Analysis (2021-2030) ($MN)
  • Table 32 Global Genomics Market Outlook, By Functional Genomics (2021-2030) ($MN)
  • Table 33 Global Genomics Market Outlook, By Real-Time PCR (2021-2030) ($MN)
  • Table 34 Global Genomics Market Outlook, By Mutational Analysis (2021-2030) ($MN)
  • Table 35 Global Genomics Market Outlook, By RNA Interference (2021-2030) ($MN)
  • Table 36 Global Genomics Market Outlook, By SNP Analysis (2021-2030) ($MN)
  • Table 37 Global Genomics Market Outlook, By Transfection (2021-2030) ($MN)
  • Table 38 Global Genomics Market Outlook, By Microarray Analysis (2021-2030) ($MN)
  • Table 39 Global Genomics Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 40 Global Genomics Market Outlook, By Application (2021-2030) ($MN)
  • Table 41 Global Genomics Market Outlook, By Agriculture and Animal research (2021-2030) ($MN)
  • Table 42 Global Genomics Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
  • Table 43 Global Genomics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 44 Global Genomics Market Outlook, By Biofuel Research (2021-2030) ($MN)
  • Table 45 Global Genomics Market Outlook, By Marine Research (2021-2030) ($MN)
  • Table 46 Global Genomics Market Outlook, By Food Industry (2021-2030) ($MN)
  • Table 47 Global Genomics Market Outlook, By Forensics (2021-2030) ($MN)
  • Table 48 Global Genomics Market Outlook, By End User (2021-2030) ($MN)
  • Table 49 Global Genomics Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 50 Global Genomics Market Outlook, By Hospitals and Clinics (2021-2030) ($MN)
  • Table 51 Global Genomics Market Outlook, By Diagnostics Centers (2021-2030) ($MN)
  • Table 52 Global Genomics Market Outlook, By Academic Institutes (2021-2030) ($MN)
  • Table 53 Global Genomics Market Outlook, By Clinical Research (2021-2030) ($MN)
  • Table 54 Global Genomics Market Outlook, By Healthcare Facilities (2021-2030) ($MN)
  • Table 55 Global Genomics Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.